Single answer
Is Adial Pharmaceuticals Inc (ADIL) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Adial Pharmaceuticals Inc a clinicalstage biopharmaceutical company focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders Its lead product is AD04 a selective serotonin3 antagonist which is in Phase III clinical trial for the treatment of alcohol use disorder The company also focuses on developing drug candidates for nonopioid pain reduction and other diseases and disorders Adial Pharmaceuticals Inc was founded in 2010 and is based in Charlottesville Virginia
Website: https://www.adialpharma.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.00. Cash flow to debt ratio: 0.00. Net profit margin: -1,427,620.00%. Inflation risk score: medium (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for Adial Pharmaceuticals Inc is $189,236. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
We cannot find data for Adial Pharmaceuticals Inc 10 years ago, but if you had invested on 2018-07-27 when the price was $101.25, you would have made a loss of $101.02 per share or 99.77%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.